Pacira | PCRX - Assets


Pacira reported $1.3B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Astellas Pharma JPY 3.45T 114.46B Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Ironwood Pharmaceuticals USD 396.06M 53.12M Sep/2025
J&J USD 192.82B 573M Sep/2025
Ligand Pharmaceuticals USD 1.48B 528.17M Sep/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025
Zoetis USD 15.16B 680M Sep/2025